vs
Side-by-side financial comparison of GAXOS.AI INC. (GXAI) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.
GAXOS.AI INC. is the larger business by last-quarter revenue ($1.2M vs $1.1M, roughly 1.1× Insight Molecular Diagnostics Inc.). GAXOS.AI INC. runs the higher net margin — -77.2% vs -2015.4%, a 1938.1% gap on every dollar of revenue. On growth, GAXOS.AI INC. posted the faster year-over-year revenue change (94996.3% vs -23.4%).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
GXAI vs IMDX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.1M |
| Net Profit | $-957.9K | $-23.0M |
| Gross Margin | — | 42.5% |
| Operating Margin | -99.0% | -2057.5% |
| Net Margin | -77.2% | -2015.4% |
| Revenue YoY | 94996.3% | -23.4% |
| Net Profit YoY | -15.1% | 31.5% |
| EPS (diluted) | $-0.13 | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2M | $1.1M | ||
| Q3 25 | $498.3K | $260.0K | ||
| Q2 25 | $171.0K | $518.0K | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $115.0K | ||
| Q2 24 | $0 | $104.0K | ||
| Q1 24 | — | $176.0K |
| Q4 25 | $-957.9K | $-23.0M | ||
| Q3 25 | $-1.0M | $-10.9M | ||
| Q2 25 | $-749.4K | $-9.7M | ||
| Q1 25 | — | $-6.7M | ||
| Q4 24 | — | $-33.5M | ||
| Q3 24 | — | $-13.5M | ||
| Q2 24 | $-809.2K | $-4.5M | ||
| Q1 24 | — | $-9.1M |
| Q4 25 | — | 42.5% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 67.6% | ||
| Q1 25 | — | 62.0% | ||
| Q4 24 | — | 40.0% | ||
| Q3 24 | — | 43.5% | ||
| Q2 24 | — | 48.1% | ||
| Q1 24 | — | 25.6% |
| Q4 25 | -99.0% | -2057.5% | ||
| Q3 25 | -263.9% | -4249.2% | ||
| Q2 25 | -574.8% | -1900.0% | ||
| Q1 25 | — | -318.0% | ||
| Q4 24 | — | -2262.9% | ||
| Q3 24 | — | -11752.2% | ||
| Q2 24 | — | -4453.8% | ||
| Q1 24 | — | -5265.3% |
| Q4 25 | -77.2% | -2015.4% | ||
| Q3 25 | -201.0% | -4174.6% | ||
| Q2 25 | -438.3% | -1880.7% | ||
| Q1 25 | — | -312.0% | ||
| Q4 24 | — | -2255.1% | ||
| Q3 24 | — | -11733.0% | ||
| Q2 24 | — | -4355.8% | ||
| Q1 24 | — | -5186.9% |
| Q4 25 | $-0.13 | $-0.75 | ||
| Q3 25 | $-0.14 | $-0.34 | ||
| Q2 25 | $-0.11 | $-0.30 | ||
| Q1 25 | — | $-0.26 | ||
| Q4 24 | — | $-2.19 | ||
| Q3 24 | — | $-0.98 | ||
| Q2 24 | $-0.72 | $-0.36 | ||
| Q1 24 | — | $-1.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $840.5K | $11.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.1M | $-31.5M |
| Total Assets | $13.4M | $25.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $840.5K | $11.6M | ||
| Q3 25 | — | $18.7M | ||
| Q2 25 | — | $24.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $8.6M | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | $4.5M | $9.3M | ||
| Q1 24 | — | $5.6M |
| Q4 25 | $13.1M | $-31.5M | ||
| Q3 25 | $14.1M | $-9.2M | ||
| Q2 25 | $15.0M | $1.1M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $-12.3M | ||
| Q3 24 | — | $9.7M | ||
| Q2 24 | $4.7M | $22.7M | ||
| Q1 24 | — | $11.6M |
| Q4 25 | $13.4M | $25.8M | ||
| Q3 25 | $14.3M | $43.9M | ||
| Q2 25 | $15.4M | $50.5M | ||
| Q1 25 | — | $60.4M | ||
| Q4 24 | — | $35.1M | ||
| Q3 24 | — | $70.2M | ||
| Q2 24 | $5.1M | $74.7M | ||
| Q1 24 | — | $71.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-733.1K | $-5.5M |
| Free Cash FlowOCF − Capex | — | $-7.0M |
| FCF MarginFCF / Revenue | — | -616.7% |
| Capex IntensityCapex / Revenue | — | 129.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-733.1K | $-5.5M | ||
| Q3 25 | $-1.1M | $-4.5M | ||
| Q2 25 | $-716.9K | $-6.3M | ||
| Q1 25 | — | $-5.9M | ||
| Q4 24 | — | $-5.4M | ||
| Q3 24 | — | $-5.5M | ||
| Q2 24 | $-738.5K | $-6.0M | ||
| Q1 24 | — | $-3.8M |
| Q4 25 | — | $-7.0M | ||
| Q3 25 | — | $-5.6M | ||
| Q2 25 | — | $-6.6M | ||
| Q1 25 | — | $-6.2M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | — | $-5.6M | ||
| Q2 24 | — | $-6.2M | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | — | -616.7% | ||
| Q3 25 | — | -2135.4% | ||
| Q2 25 | — | -1279.5% | ||
| Q1 25 | — | -288.4% | ||
| Q4 24 | — | -374.5% | ||
| Q3 24 | — | -4884.3% | ||
| Q2 24 | — | -5931.7% | ||
| Q1 24 | — | -2189.8% |
| Q4 25 | — | 129.9% | ||
| Q3 25 | — | 403.8% | ||
| Q2 25 | — | 67.4% | ||
| Q1 25 | — | 14.4% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 75.7% | ||
| Q2 24 | — | 183.7% | ||
| Q1 24 | — | 13.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
